SCHEMBL15328448

SCHEMBL15328448

Cc1cc(N2CCOCC2)cc(N2CC[C@@H](F)C2)c1C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGMN Q99538 2/20 0.43
ALDH1A1 P00352 4/20 0.40
MAPT P10636 4/20 0.40
GAA P10253 1/20 0.38
LMNA P02545 1/20 0.37
IKBKB O14920 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAOA P21397 1/20 0.35
KDM4E B2RXH2 2/20 0.35
PIK3R1 P27986 1/20 0.35
PIK3CA P42336 1/20 0.35
MTOR P42345 1/20 0.35
CSNK1E P49674 1/20 0.35
F10 P00742 1/20 0.35
PARP1 P09874 1/20 0.35
HPGD P15428 1/20 0.34
MYC P01106 2/20 0.34
WDR5 P61964 2/20 0.34
MAPK1 P28482 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2770127 0.81 MAPT (0.49) ALDH1A1MAPTGAALMNAIKBKB
SCHEMBL15328446 0.77 KMT2A (0.44) ALDH1A1LMNAMEN1KMT2AF10
SCHEMBL10316580 0.77 IKBKB (0.47) ALDH1A1MAPTGAAIKBKBMEN1
SCHEMBL15328672 0.76 ALDH1A1 (0.45) LGMNALDH1A1MAPTLMNAMEN1
SCHEMBL2770539 0.74 PIK3C2B (0.44) ALDH1A1MAPTGAALMNAMEN1
SCHEMBL10316620 0.74 IKBKB (0.44) ALDH1A1MAPTGAAIKBKBKDM4E
SCHEMBL2771885 0.73 MAPT (0.47) ALDH1A1MAPTGAALMNAMEN1
SCHEMBL15328674 0.73 MAPT (0.42) ALDH1A1MAPTGAALMNAIKBKB
SCHEMBL15328513 0.72 MAPT (0.40) LGMNALDH1A1MAPTGAALMNA
SCHEMBL15328356 0.70 ALDH1A1 (0.44) ALDH1A1MAPTGAALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9108936-B2 Substituted 4-aminobenzamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2015-08-18 US disclosed
EP-2844645-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2015-03-11 EP disclosed
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2013-10-24 US disclosed
WO-2013156155-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2013-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS KCNJ2, KCNQ2, KCNQ1 LGMN 3669/4885ALDH1A1 3041/4885MAPT 3816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.